Pfizer’s boss thinks covid-19 is reshaping Big Pharma for the better

“THE IMPOSSIBLE can many times become possible,” reflects Albert Bourla, boss of Pfizer. He is talking about the giant American drugmaker’s speedy development (with BioNTech of Germany) of a vaccine against covid-19. The sentiment also applies to the turnaround in the fortunes of the pharmaceutical industry.

Listen to this story

Your browser does not support the <audio> element.

Before the pandemic Big Pharma was in big trouble. It was widely criticised for investing more in marketing than in research, for pursuing “me too” drugs over novel therapies, and for alleged price-gouging. When Gallup, a pollster, asked Americans in 2019 to rank two dozen big industries by favourability, the

→ Continue reading at The Economist

Similar Articles


Most Popular

Canada's COVID-19 surge shows danger of virus variants

Washington's border crossing with Canada will stay closed to non-essential travel until at least April 21. SEATTLE — Canada is experiencing a surge...

Top Gun: Maverick is the latest major blockbuster to skip the summer movie season

Top Gun: Maverick, the sequel to the ’80s classic Top Gun starring Tom Cruise, will now premiere on November 19th, according to Deadline. It...

Oculus will host its first games showcase on April 21st

Later this month, Oculus will host its first games showcase. The event will include announcements about updates to current games, new footage from upcoming...